Exploració per tema "Cancer--Treatment"

Ara es mostren els items 1-11 de 11

    • Electrospray loading and release of hydrophobic gramicidin in polyester microparticles 

      Maione, Silvana; Valle Mendoza, Luis Javier del; Pérez Madrigal, Mª del Mar; Cativiela, Carlos; Puiggalí Bellalta, Jordi; Alemán Llansó, Carlos (2016)
      Article
      Accés restringit per política de l'editorial
      Gramicidin (GA), a very hydrophobic pentadecapeptide with important biological activities (i.e. in addition to its well-known antimicrobial and antibiotic activities, GA has been recently identified as a potent therapeutic ...

    • Engineered microtissues for the bystander therapy against cancer 

      Blanco Fernández, Bárbara; Cano Torres, Irene; Garrido, Cristina; Rubi Sans, Gerard; Sanchez Cid, Lourdes; Guerra Rebollo, Marta; Rubio, Nuria; Blanco, Jeronimo; Pérez Amodio, Soledad Graciela; Mateos Timoneda, Miguel Ángel; Engel López, Elisabeth (Elsevier, 2021-02-01)
      Article
      Accés obert
      Thymidine kinase expressing human adipose mesenchymal stem cells (TK-hAMSCs) in combination with ganciclovir (GCV) are an effective platform for antitumor bystander therapy in mice models. However, this strategy requires ...

    • Green metallic nanoparticles for cancer therapy: evaluation models and cancer applications 

      Tinajero, Ernesto; Salado Leza, Daniela; González Castillo, María del Carmen; Martínez Velázquez, Moisés; López, Zaira; Bravo Madrigal, Jorge; Knauth, Peter; Flores Hernández, Flor Y.; Herrera Rodríguez, Sara Elisa; Navarro González, Rosa Estela; Cabrera Wrooman, Alejandro; Krotzsch, Edgar; García Carvajal, Zaira Yunuen; Hernández Gutiérrez, Rodolfo (2021-10-18)
      Article
      Accés obert
      Metal-based nanoparticles are widely used to deliver bioactive molecules and drugs to improve cancer therapy. Several research works have highlighted the synthesis of gold and silver nanoparticles by green chemistry, using ...

    • Lessons learnt with plasma-treated liquid therapies for bone cancer: opportunities for plasma medicine 

      Canal Barnils, Cristina (2022)
      Text en actes de congrés
      Accés obert

    • Molecular determinants for the activation/inhibition of bak protein by BH3 peptides 

      Vila Julià, Guillem; Granadino, Jose Manuel; Pérez González, Juan Jesús; Rubio Martínez, Jaime (2020-03-23)
      Article
      Accés obert
      Apoptosis is a key cell death pathway in mammalian cells. Understanding this process and its regulation has been a subject of study in the last three decades. Members of the Bcl-2 family of proteins are involved in the ...

    • Pharmacophoric modifications lead to superpotent avß3 integrin ligands with suppressed a5ß1 activity 

      Neubauer, Stefanie; Rechenmacher, Florian; Brimioulle, Richard; Di Leva, Francisco Saverio; Bochen, Alexander; Sobahi, Tariq R.; Schottelius, Margret; Novellino, Ettore; Mas Moruno, Carlos; Marinelli, Luciana; Kessler, Horst (2014-04-24)
      Article
      Accés restringit per política de l'editorial
      Realitzat a/amb:   Technische Universität München
      The selective targeting of the avß3 integrin subtype without affecting the structurally closely related receptor a5ß1 is crucial for understanding the details of their biological and pathological functions and thus of great ...

    • Plasma-conditioned liquids as anticancer therapies in vivo: current state and future directions 

      Solé Martí, Xavier; Espona Noguera, Albert; Ginebra Molins, Maria Pau; Canal Barnils, Cristina (2021-01-25)
      Article
      Accés obert
      Plasma-conditioned liquids (PCL) are gaining increasing attention in the medical field, especially in oncology, and translation to the clinics is advancing on a good path. This emerging technology involving cold plasmas ...

    • Plasma-conditioned liquids in bone cancer therapy 

      Tampieri, Francesco; Labay, Cédric Pierre; Espona Noguera, Albert; Solé Martí, Xavier; Mateu Sanz, Miguel; Tornín, Juan; Canal Barnils, Cristina (2022)
      Text en actes de congrés
      Accés obert

    • Recent advances in the treatment of bone cancer with plasma-conditioned liquids 

      Canal Barnils, Cristina (2022)
      Text en actes de congrés
      Accés obert

    • The multikinase inhibitor EC‐70124 synergistically increased the antitumor activity of doxorubicin in sarcomas 

      Estupiñan, Oscar; Santos, Laura; Rodriguez, Aida; Fernandez-Nevado, Lucia; Costales, Paula; Perez‐Escuredo, Jhudit; Hermosilla, Maria Ana; Oro, Patricia; Rey, Veronica; Tornin Cavielles, Juan; Allonca, Eva; Fernandez Garcia, Maria Teresa; Alvarez Fernandez, Carlos; Braña, Alejandro; Astudillo, Aurora; Menendez, Sofia T.; Moris, Francisco; Rodriguez, Rene (Wiley (John Wiley & Sons), 2018-12-21)
      Article
      Accés obert
      Cytotoxic drugs like doxorubicin remain as the most utilized agents in sarcoma treatment. However, advanced sarcomas are often resistant, thus stressing the need for new therapies aimed to overcome this resistance. Multikinase ...

    • Weighing biointeractions between fibrin (ogen) and clot-binding peptides using microcantilever sensors 

      Puiggalí Jou, Anna; Valle Mendoza, Luis Javier del; Alemán Llansó, Carlos; Pérez Madrigal, Mª del Mar (2017-02-01)
      Article
      Accés obert
      Peptides homing tumor vasculature are considered promising molecular imaging agents for cancer detection at an early stage. In addition to their high binding affinity, improved tissue penetrating ability, and low immunogenicity, ...